Why the study?
Cigarette smoking is an established risk factor for coronary artery disease, but its specific impact on angiographic profile and immediate outcomes in young STEMI patients without other cardiac risk factors warranted comparison.
Does smoking impact the angiographic profile and immediate clinical outcomes of primary PCI in young males with STEMI without other conventional risk factors?
Does smoking impact the angiographic profile and immediate clinical outcomes of primary PCI in young males with STEMI without other conventional risk factors?
In young males presenting with STEMI without other conventional risk factors, smoking status does not significantly alter the angiographic profile or immediate in-hospital outcomes following primary PCI.
No smoking impact on angiographic profile or immediate PCI outcomes in young male STEMI; leaves open longer-term effects and need for prospective studies.
Introduction Cigarette smoking is a well-established risk factor for the development and progression of coronary artery disease (CAD) and it is strongly related to cardiac morbidity and mortality. Therefore, this study aimed to compare the angiographic profile and immediate clinical outcomes in young male smokers and non-smokers without any other cardiac risk factors presented with ST-elevation myocardial infarction (STEMI). Methods This study includes young (≤40 years) male patients presented without cardiac risk factors other than smoking. Angiographic profile and immediate outcome of primary percutaneous coronary intervention (PCI) were collected from the hospital database. Results A total of 580 young male patients were included in this study, 51.2% (297) were smokers. Baseline characteristics and presentation were similar for smoker and non-smoker groups. Angiographic profile was not significantly different for smokers in terms of pre-procedure thrombolysis in myocardial infarction (TIMI) flow (p = 0.373), the number of vessels involved (p = 0.813), infarct-related artery (p = 0.834), and left ventricular dysfunction (p = 0.311). Similarly, in-hospital outcomes of primary PCI were not significantly different in smokers. Post-procedure no-reflow was in 3.4% vs. 2.8%; p = 0.708, acute stent thrombosis in 1.7% vs. 0.4%; p = 0.114 and in-hospital mortality in 1.0% vs. 1.4%; p = 0.657 of the smoker and non-smoker group, respectively. Conclusion Our study concludes smoking has no significant impact on the angiographic profile and immediate clinical outcomes of primary PCI after STEMI in young males, without any other conventional cardiac risk factors. With these findings, further multicenter prospective studies are needed to identify other potential causes in such patients.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: